We found that monoallelic del(11q) CLLs may harbor additional del(17p) and/or TP53 mutations, whereas biallelic loss of ATM and TP53 is virtually inexistent and therefore mutually exclusive in CLL patients. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.